The global biochemical diagnostic reagent market size will be USD 24581.2 million in 2024.

According to cognitive market research, the global biochemical diagnostic reagent market size will be USD 24581.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.80% from 2024 to 2031.North America held the major market share for more than 40% of the global revenue with a market size of USD 9832.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.Europe accounted for a market share of over 30% of the global revenue with a market size of USD 7374.36 million.Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 5653.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.Latin America had a market share of more than 5% of the global revenue with a market size of USD 1229.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 491.62 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.The assay kits category is the fastest growing segment of the biochemical diagnostic reagent industry  Market Dynamics of Biochemical Diagnostic Reagent MarketKey Drivers for Biochemical Diagnostic Reagent MarketIncreasing the Pharmaceutical & Biotechnology Industry to Boost Market GrowthThe worldwide pharmaceutical sector is rapidly expanding. This growth is ascribed to a variety of factors, including patent expirations, the introduction of new pharmaceuticals, and increased access to medicines in rural places. For example, in 2021, Pharmaceutical Research and Manufacturers of America (PhRMA) member companies spent USD 102.3 billion on research and development (Source: 2022 PhRMA member annual survey). Biochemical reagents are important in the pharmaceutical industry because they can be used to determine pharmaceutical formulations quantitatively and qualitatively. Furthermore, in drug discovery, these reagents are useful in examining elements, compounds, and reactions controlled by biomolecules within living organisms, which aids in the creation of new medicines. For instance, Roche, a global leader, provides a wide range of biochemical diagnostic reagents for clinical chemistry and immunoassay testing. Their product portfolio advances diagnostics by providing solutions that provide accurate and timely findings, benefiting the healthcare and pharmaceutical industries.Growth in Food & Beverage Industry to Drive Market GrowthBiochemical reagents serve an important part in both food production and quality control tests. Gas chromatography (GC) analysis is used to detect flavors and fragrances, as well as to determine pollutants like pesticide residues, which drives demand for chromatography reagents in the food and beverage industry. Furthermore, biochemical reagents, frequently in conjunction with kit systems or strips, are used to identify and confirm microorganisms in foods. The increasing use of biochemical reagents in the food and beverage industry fuels the biochemical reagents market.Restraint Factor for the Biochemical Diagnostic Reagent MarketStringent Regulatory Frameworks Will Limit Market GrowthThe worldwide diagnostic reagents market confronts hurdles as a result of stringent regulatory requirements. Complex clearance processes, high-quality standards, and compliance requirements can stymie market expansion while increasing the time and cost of product creation.Impact of Covid-19 on the Biochemical Diagnostic Reagent MarketCovid-19 had a significant impact on the biochemical diagnostic reagent market. Pharmaceutical and biotech businesses, along with governments around the world, are striving to handle the COVID-19 outbreak, from vaccine development to pharmaceutical supply chain planning. Currently, the R&D pipeline includes approximately 115 vaccine candidates and 155 compounds. Furthermore, routinely used medications such as hydroxychloroquine have shown a significant increase in demand for COVID-19 treatment. Because many affluent countries are experiencing a shortage of these pharmaceuticals, the strong demand for them has created enormous potential for manufacturers of COVID-19 management medications. Thus, the biotechnology business is likely to expand significantly in the fu...

根据认知市场研究，预计到2024年，全球生化诊断试剂市场规模将达到245.81亿美元。从2024年至2031年，该市场规模将以8.80%的复合年增长率（CAGR）持续扩张。北美在全球收入中占据主导地位，市场份额超过40%，2024年的市场规模为98.32亿美元，预计从2024年至2031年的复合年增长率为7.0%。欧洲在全球收入中占比超过30%，2024年的市场规模为73.74亿美元。亚太地区在全球收入中占比约为23%，2024年的市场规模为56.54亿美元，预计从2024年至2031年的复合年增长率为10.8%。拉丁美洲在全球收入中占比超过5%，2024年的市场规模为12.29亿美元，预计从2024年至2031年的复合年增长率为8.2%。中东和非洲在全球收入中占比约为2%，2024年的市场规模估计为4.92亿美元，预计从2024年至2031年的复合年增长率为8.5%。在生化诊断试剂行业中，试剂试剂盒类别是增长最快的部分。生化诊断试剂市场的市场动态包括市场驱动力、市场增长因素、制药及生物技术行业的增长对市场增长的推动作用、食品及饮料行业的增长推动市场增长、市场增长的限制因素，即严格的监管框架将限制市场增长，以及新冠疫情对生化诊断试剂市场的影响。